Innovation through Technology for a Sustainable, Greener and a better World.
Innovative solutions
to support Human needs
At Olusium, we are proud to be a diverse and inclusive community that is made up of researchers, engineers, artists, scientists, designers, makers, doctors, and more. What unites us is a shared passion for harnessing the newest and latest technology to improve the lives of people around the world. We believe that by working together, we can leverage our collective expertise and creativity to solve complex problems and push the boundaries of what is possible. As our community continues to grow, we are excited about the opportunities that lie ahead and the potential to make a meaningful impact on the world. At the core of our community is a commitment to innovation, excellence, and collaboration.
Cultivation of Young Ideas
The transformation of an idea into a concept takes path in several steps , which include idea-presentations experimentations prototyping testings and productions with our expertised team and technically equiped labs.
Investment on Technology
Our world is now in the peak of technical advancement , the role of technology in day today life is inevitable . Placing technology in the forefornt of innovation helps create a better, sustainable and more Greener world for tomorrow
Near-Field Interaction
Bringing futuristic technologies - CBI, wireless power tranfer , non invasive disease diagnostics , mind controlled devices and more in the current world making future so accessible to provide comfort at all levels.
Make a better World
Make a better World - Infusing technology in medical , transportation , waste management , farming , health care and more , We create a sustainable greener world - a safe place for the future generation.
MIMD
Olusium is a leading innovator in the field of advanced research for early-stage, non-invasive, label-free, and cost-effective cancer diagnosis. This innovation is a game-changer for the field of cancer diagnosis, as it eliminates the need for invasive biopsies and costly imaging tests. By providing a more accurate and cost-effective diagnostic method, Olusium's technology has the potential to significantly improve cancer survival rates and reduce healthcare costs.
Overall, Olusium's groundbreaking innovation represents a significant step forward in the fight against cancer, and its impact on humanity cannot be overstated. The addition of an undercover picture would require more specific information, such as what kind of picture is desired and for what purpose.
Time -Line
We are proud to highlight our commitments of excellence to our clients and organizations. We have won many recognition from our Business Partner,and Government entities.
CSIR-NIIST
26-07-2024CSIR-NIIST - Golden Jubilee Curtain Raiser
On July 26, 2024, Olusium Technologies signed second Memorandum of Understanding (MoU) with CSIR-NIIST to initiate a multicentric phase of validation for their pioneering early-stage cancer detection technology across various geographical regions in India. The MoU was exchanged in the esteemed presence of Dr. (Mrs.) N. Kalaiselvi, Director General of CSIR and Secretary of DSIR, marking a significant milestone in the collaboration between Olusium and CSIR-NIIST. This partnership aims to rigorously test and validate the technology's efficacy in diverse clinical settings, paving the way for its widespread adoption in the early diagnosis of cancer.
CSIR-NIIST
26-07-2024CSIR-NIIST, TATA ELXSI, OLUSIUM, CANCER INSTITUTE (WIA), at Golden Jubilee Curtain Raiser Program
On July 26, 2024, Olusium Technologies officially exchanged a Memorandum of Understanding (MoU) with the Council of Scientific and Industrial Research - National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) to advance the validation of its early-stage cancer detection technology. This collaboration will involve multicentric validation phases across India, conducted in partnership with the Tata Elxsi and Cancer Institute (WIA). The MoU exchange took place in the esteemed presence of Dr. (Mrs.) N. Kalaiselvi, Director General of CSIR and Secretary of the Department of Scientific and Industrial Research (DSIR), marking a significant milestone in the pursuit of cutting-edge, non-invasive diagnostic solutions for cancer.
OLUSIUMS's Featured Technologies
OLUSIUMS's approach to research draws from more than 6 years of work, over the course of which it has developed its own systemic and user-centered approach to research and innovation. Our research processes focus on uncovering latent needs, understanding user patterns, behaviors, expectations and desires in order to innovate in strategic business, service, product, and system solutions.
Our Research
Association & Collaboration
Partnerships & Alliances
Olusium values research collaboration and maintains strong partnerships with a variety of academic institutions, research organizations, and industry partners. These collaborations are critical to the company's success in developing innovative technologies and bringing them to market.
The value of research collaboration and association that Olusium holds with their partners cannot be overstated. These collaborations have the potential to drive innovation, accelerate research progress, and create new opportunities for all parties involved.
